Explore our end-to-end, full service clinical development capabilities including Therapeutics expertise, Development Planning, Phase I early clinical development, Phase IIb/III and Phase IV Trials, Regulatory Submission and Post-Launch Studies.


IQVIA at ASCO 2026 Annual Meeting - Meet us at booth #36069
The global oncology community will be at the 2026 ASCO Annual Meeting, May 29 - June 2, in Chicago. The theme of the meeting is, The Science and Practice of Translation: Improving Cancer Outcomes Worldwide, and will be complemented by worldwide oncology professionals coming together and forging collaborations to change the landscape of cancer care.
Stop by booth # 36069 to say hello. Our dedicated experts across IQVIA, IQVIA Laboratories and IQVIA Biotech will be there to discuss how to support your oncology study from trial design and delivery to commercial optimization. Request a meeting with them to discuss your specific challenges or learn how we can help make intelligent connections to accelerate oncology breakthroughs.
We hope to see you in Chicago!
For more information about ASCO 2026, please visit: https://conferences.asco.org/am/attend
Explore our end-to-end, full service clinical development capabilities including Therapeutics expertise, Development Planning, Phase I early clinical development, Phase IIb/III and Phase IV Trials, Regulatory Submission and Post-Launch Studies.
Focus oncology development on the patient, manage trial complexity, and increase predictability and speed.